SPL 2.11% 9.3¢ starpharma holdings limited

Starpharma's Radiotherapeutics and Telix's Molecularly Targeted Radiation platform, page-2

  1. 3,349 Posts.
    lightbulb Created with Sketch. 793
    The reason no value is ascribed to SPL’s Dep pharmaceuticals is that they are still testing candidates pre-clinical. Whereas Telix have 5 candidates in clinical trials including two in Phase 3 and two in Phase 3....
 
watchlist Created with Sketch. Add SPL (ASX) to my watchlist
(20min delay)
Last
9.3¢
Change
-0.002(2.11%)
Mkt cap ! $38.35M
Open High Low Value Volume
9.5¢ 9.5¢ 9.3¢ $48.64K 512.2K

Buyers (Bids)

No. Vol. Price($)
3 153365 9.3¢
 

Sellers (Offers)

Price($) Vol. No.
9.8¢ 65000 1
View Market Depth
Last trade - 16.10pm 02/08/2024 (20 minute delay) ?
SPL (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.